OVO Biomanufacturing
Novel technology platform that reduces generation and effects of defective interfering particles to deliver multi-fold yield improvements in viral vaccine manufacturing.
Applicable across all stages for both live-attenuated and inactivated vaccines and integrates with minimal process or regulatory changes.
Employees
loading...
Funding Status
loading...
Established
loading...
Total Funding
loading...
ARR
loading...
Insights
Loading Insights...
Loading Insight content to display...
Loading Insights...
Loading Insight content to display...
Founders
loading...
Notable Customers
loading...
Funding
Workforce
Functional Distribution
N/A
Open Positions
N/A
Diversity
N/A